Literature DB >> 7759884

Monocyte chemoattractant protein-3, but not monocyte chemoattractant protein-2, is a functional ligand of the human monocyte chemoattractant protein-1 receptor.

C Franci1, L M Wong, J Van Damme, P Proost, I F Charo.   

Abstract

Monocyte chemoattractant protein (MCP)-2 and -3 are recently identified members of the Cys-Cys chemokine family and are highly homologous to MCP-1. MCP-1, MCP-2, and MCP-3 are potent chemoattractants for monocytes, basophils, and T lymphocytes. In this study, we have examined potential interactions of MCP-2 and MCP-3 with the recently cloned MCP-1 receptor. MCP-3, but not MCP-2, induced a robust and dose-dependent mobilization of intracellular calcium in HEK-293 cells that had been stably transfected with the MCP-1 receptor. The kinetics of these calcium transients were similar to those elicited by MCP-1. MCP-1 and MCP-3 induced potent inhibition of adenylyl cyclase (concentrations giving 50% inhibition = 48 pM and 67 pM, respectively). MCP-3 bound to HEK-293 cells stably expressing the MCP-1 receptor, but with approximately 35-fold lower affinity than MCP-1. MCP-1 desensitized transfected HEK-293 cells expressing the MCP-1 receptor to activation by MCP-3 in the calcium mobilization assay, but MCP-3 did not effectively desensitize these cells to MCP-1. We conclude that MCP-3, but not MCP-2, is a functional ligand for the MCP-1 receptor.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7759884

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  31 in total

1.  Leucocyte chemotaxis: Examination of mitogen-activated protein kinase and phosphoinositide 3-kinase activation by Monocyte Chemoattractant Proteins-1, -2, -3 and -4.

Authors:  J H Wain; J A Kirby; S Ali
Journal:  Clin Exp Immunol       Date:  2002-03       Impact factor: 4.330

2.  HIV-1 envelope gp41 is a potent inhibitor of chemoattractant receptor expression and function in monocytes.

Authors:  H Ueda; O M Howard; M C Grimm; S B Su; W Gong; G Evans; F W Ruscetti; J J Oppenheim; J M Wang
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

3.  Human beta-defensin 2 and 3 and their mouse orthologs induce chemotaxis through interaction with CCR2.

Authors:  Johann Röhrl; De Yang; Joost J Oppenheim; Thomas Hehlgans
Journal:  J Immunol       Date:  2010-05-17       Impact factor: 5.422

Review 4.  Role of CCR2 in inflammatory conditions of the central nervous system.

Authors:  Hannah X Chu; Thiruma V Arumugam; Mathias Gelderblom; Tim Magnus; Grant R Drummond; Christopher G Sobey
Journal:  J Cereb Blood Flow Metab       Date:  2014-07-02       Impact factor: 6.200

Review 5.  Neurobiology of microglial action in CNS injuries: receptor-mediated signaling mechanisms and functional roles.

Authors:  Xiaoming Hu; Anthony K F Liou; Rehana K Leak; Mingyue Xu; Chengrui An; Jun Suenaga; Yejie Shi; Yanqin Gao; Ping Zheng; Jun Chen
Journal:  Prog Neurobiol       Date:  2014-06-09       Impact factor: 11.685

6.  RNA sequencing and transcriptomal analysis of human monocyte to macrophage differentiation.

Authors:  Chunsheng Dong; Guoping Zhao; Mei Zhong; Yan Yue; Li Wu; Sidong Xiong
Journal:  Gene       Date:  2013-02-28       Impact factor: 3.688

7.  Regulation of inflammatory monocyte/macrophage recruitment from the bone marrow during murine cytomegalovirus infection: role for type I interferons in localized induction of CCR2 ligands.

Authors:  Meredith J Crane; Kirsten L Hokeness-Antonelli; Thais P Salazar-Mather
Journal:  J Immunol       Date:  2009-07-20       Impact factor: 5.422

8.  Monocyte chemoattractant protein-1 promotes macrophage-mediated tubular injury, but not glomerular injury, in nephrotoxic serum nephritis.

Authors:  G H Tesch; A Schwarting; K Kinoshita; H Y Lan; B J Rollins; V R Kelley
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

9.  Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice.

Authors:  L Boring; J Gosling; S W Chensue; S L Kunkel; R V Farese; H E Broxmeyer; I F Charo
Journal:  J Clin Invest       Date:  1997-11-15       Impact factor: 14.808

10.  CCL2 in the Tumor Microenvironment.

Authors:  Tracy O'Connor; Mathias Heikenwalder
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.